Switching from Tirzepatide to Retatrutide: Protocol and Washout Guide

You hit the plateau. Tirzepatide worked for months, then it didn't, and the scale stopped moving even at your max dose. Retatrutide is the natural next move for most people in that spot, but the part that stalls everyone is the same: how do you actually make the switch, and what happens to your body in the gap between the last tirz shot and the first reta one.

Short version: there's a one-week washout, you start reta low regardless of your tirz dose, and the first few weeks feel like going backwards before they don't. Below is the protocol, week by week, with what to expect at each stage.

The Quick Answer

Take your last tirzepatide dose on your normal schedule. Wait 7 days (one full washout week). Start retatrutide at 2mg regardless of what dose of tirzepatide you were on. The glucagon receptor in reta is pharmacologically new to your body, so the tolerance-building ramp cannot be skipped.

The Bottom Line

Switching from tirzepatide ("tirz") to retatrutide ("reta") is the most common GLP-1 upgrade path — typically triggered by a weight loss plateau on tirzepatide. The protocol: take your last tirzepatide dose, wait one week for washout, then start retatrutide at 2mg/week regardless of your previous tirzepatide dose. The glucagon receptor in retatrutide is pharmacologically new to your body, so the tolerance-building phase cannot be skipped. Most users report breaking through their tirzepatide plateau within 2-3 weeks of starting retatrutide, with the return of strong appetite suppression plus noticeable increases in body heat and metabolic rate. Track your transition with the Regimen app to log doses, weight, and side effects across both compounds.

How to Switch from Tirzepatide to Retatrutide: The Step-by-Step Process

Switching from tirzepatide to retatrutide is something a growing number of people in the GLP-1 community are doing in 2026. The transition isn't complicated, but doing it right matters: managing the washout, adjusting dose, and avoiding the rebound hunger that hits when you taper off one compound before fully on-ramping the other.

Here's the process most people follow, broken into the decisions and steps that actually matter.

Step 1: Decide your timing. Most people transition at a natural decision point: end of a vial, end of a maintenance month, or after a planned break. There's no medical reason it has to be one or the other. The question is when works for your schedule.

Step 2: Plan your washout (or skip it). Tirzepatide has a half-life of about 5 days. After your last tirzepatide dose, the compound is largely cleared from your system in 4-5 weeks. Some people wait 1-2 weeks before starting retatrutide to let levels drop, reducing the chance of compound stacking and side effects. Others switch immediately and ramp retatrutide low. Both approaches are common in the community. Talk to your prescribing doctor about which makes sense for you.

Step 3: Start retatrutide at a conservative dose. Even if you were on a high tirzepatide dose, the community pattern is to start retatrutide at the lower trial doses (2mg or 4mg weekly). The compounds are similar but not identical, and your body adjusts. Going up gradually is easier than coming down from too much.

Step 4: Watch for rebound hunger and food noise. The most common report from people switching: hunger and food noise return for a week or two before retatrutide takes full effect. This is the gap between tirzepatide clearing and retatrutide saturating. Plan for it. Don't panic.

Step 5: Track your protocol carefully during the transition. This is exactly when tracking matters most. Dose dates, side effects, weight, hunger ratings, and any blood work all become more useful when you're dialing in a new protocol. Track your transition with Regimen.

Switching from Tirzepatide to Retatrutide: What the Clinical Trial Data Shows

The TRIUMPH and ATTAIN clinical trials for retatrutide (Eli Lilly) used the standard sequential approach: patients on prior GLP-1 therapy washed out before enrolling. The trial data doesn't directly cover compound-to-compound switching, but it does establish baseline tolerability:

Retatrutide trial doses ranged from 1mg to 12mg weekly, with most maintenance protocols landing at 8-12mg.
Tirzepatide maintenance is typically 10-15mg weekly.
The dose ranges are similar, but the compounds bind different receptors. Tirzepatide is a GIP/GLP-1 dual agonist; retatrutide is a GIP/GLP-1/glucagon triple agonist. The third pathway is what differentiates retatrutide for fat loss specifically.

What the community is reporting in 2026: people switching from tirzepatide to retatrutide for plateau-breaking are seeing weight loss resumption within 4-8 weeks of the transition, but with a transition period of 1-3 weeks of return hunger and reduced compound effect.

This isn't a recommendation to switch. It's context for those who are considering it under medical supervision.

When to Consider Switching

Switching from tirzepatide to retatrutide makes sense when:

You've genuinely plateaued on tirzepatide — weight loss has stalled for 4+ weeks at your maximum tolerated dose despite consistent compliance
You've optimized the basics first — protein intake (1.2-1.6g/kg/day), exercise, sleep, and hydration are all dialed in. A plateau on tirz with poor diet is not a reason to switch compounds — it's a reason to fix your diet
You've tried split dosing — some tirzepatide plateaus are actually dose-timing issues. Splitting your weekly dose into 2 injections can restart weight loss without switching compounds
You're working with a provider — someone who can monitor labs, adjust dosing, and manage the transition medically
You understand the trade-offs — retatrutide is not FDA-approved, has stronger side effects, costs more, and has less long-term safety data than tirzepatide

Warning

Retatrutide is in Phase 3 clinical trials and not FDA-approved. This switching guide is based on community protocols and provider experience, not randomized switching studies. Always work with a licensed healthcare provider when transitioning between GLP-1 compounds.

Do NOT switch if:

You've been on tirzepatide for less than 6 months (give it time)
You haven't reached at least 10mg tirzepatide (you may not have hit your effective dose yet)
Your plateau is less than 4 weeks old (normal weight fluctuations can mimic plateaus)
You're switching purely for faster results rather than because tirzepatide stopped working

Before You Switch: Checklist

Before your last tirzepatide dose, prepare:

Task	Why
Get baseline labs (metabolic panel, A1C, lipids)	Document where you are before the switch for comparison
Record your current weight, measurements, and progress photos	You'll want a clear "transition start" baseline
Source your retatrutide supply	Ensure you have enough for at least 8 weeks of titration (starting at 2mg)
Have BAC water and insulin syringes ready	Same supplies as tirzepatide reconstitution
Set up tracking in the Regimen app	Log your last tirz dose and first reta dose for a clean transition record
Discuss with your provider	Confirm they're comfortable monitoring the switch

The Switching Protocol (Week by Week)

1
Week 0
Last tirzepatide dose
2
Week 1
Washout (no injection)
3
Week 2
Retatrutide 2mg starts
4
Week 6
Increase to 4mg
5
Week 10
Increase to 6mg
6
Week 14+
Continue titrating

Week	What to Do	Dose	Notes
Week 0	Take your LAST tirzepatide dose	Your current tirz dose	Normal injection, last one
Week 1	Washout — no injection	None	Both compounds have ~5-6 day half-lives. This clears most tirzepatide from your system
Week 2	First retatrutide injection	2 mg	Start low regardless of previous tirz dose
Weeks 3-5	Continue retatrutide	2 mg	Assess GI tolerance to glucagon receptor activation
Week 6	First dose increase	4 mg	If tolerating 2mg well
Weeks 7-9	Continue at 4mg	4 mg	First therapeutic dose — appetite suppression returns
Week 10	Second increase	6 mg	Glucagon effects become noticeable
Week 14+	Continue titrating	8mg, 10mg, 12mg	Increase every 4 weeks as tolerated

Pro Tip

The washout week (Week 1) is optional but recommended. Some providers have patients start retatrutide the week after their last tirzepatide dose with no washout. The risk of overlapping doses is low given the half-lives, but the washout gives a cleaner baseline and lets any lingering tirzepatide side effects clear before introducing a new compound. If you skip the washout, be extra cautious about nausea in week 1 of retatrutide — you may have residual tirzepatide activity amplifying the effect.

What to Expect During Transition

Week 1 (Washout)

Appetite will gradually return as tirzepatide clears your system
You may feel hungrier than you have in months — this is normal and temporary
Weight may tick up 1-3 lbs from increased food intake and water retention — don't panic
Some people feel more energetic as the GLP-1 suppression lifts

Weeks 2-3 (First retatrutide doses at 2mg)

Mild appetite suppression returns (less than what you felt on full-dose tirzepatide)
You may notice injection site reactions — retatrutide causes more site irritation than tirzepatide for many people
Mild nausea possible but usually less than your initial tirzepatide experience
The glucagon receptor is activating but effects are subtle at 2mg

Weeks 4-6 (Increasing to 4mg)

Appetite suppression strengthens — most users report it matching or exceeding their peak tirzepatide effect
Body heat increases, especially after meals — this is the glucagon receptor at work
Some users report the "fridge doesn't call me anymore" effect returning
Weight loss typically restarts, often breaking through the tirzepatide plateau

Weeks 7+ (6mg and beyond)

Full triple-agonist effect kicks in
Weight loss accelerates beyond what tirzepatide achieved
Side effects intensify, particularly at the 6mg to 8mg transition
Most users who switched report being glad they did, but emphasize that the first 4-6 weeks require patience

Community Insight

The most common frustration during the switch: "I felt like I went backwards during the washout and first 2 weeks." Your appetite returns, the scale may go up slightly, and it can feel like you're losing progress. This is temporary. By weeks 4-6 on reta, the vast majority of users report stronger appetite suppression than they ever had on tirz, plus the added metabolic boost from the glucagon receptor. The key is trusting the process through those uncomfortable first few weeks.

Managing Side Effects During the Switch

The transition period can cause a unique mix of side effects because your body is adapting to a new receptor profile:

Side Effect	Cause	Management
Increased hunger during washout	Tirzepatide wearing off	Eat at maintenance calories — don't restrict heavily. Focus on protein
Nausea on first reta doses	GLP-1 receptor re-stimulation + new glucagon activation	Inject after a meal, evening dosing, ginger
Injection site irritation	Retatrutide causes more site reactions	Rotate sites aggressively — see injection sites guide
Body heat / sweating	Glucagon receptor activation (new)	Normal and expected — stay hydrated, dress in layers
Mild heart rate increase	Glucagon-driven metabolic increase	Monitor weekly; usually 3-7 bpm at low doses
GI changes (diarrhea or constipation)	New compound, different receptor profile	Usually resolves in 1-2 weeks; fiber and hydration help

Pro Tip

Consider split dosing from the start of retatrutide. Instead of 2mg once per week, try 1mg twice per week. This smooths out blood levels during the critical adaptation period and reduces the nausea spike. Use the split-dose calculator to calculate exact units.

Common Mistakes When Switching

Mistake	Why It's a Problem
Starting retatrutide above 2mg	The glucagon receptor is new — your body hasn't adapted to it regardless of GLP-1/GIP tolerance from tirzepatide. Starting at 4mg+ causes severe nausea
No washout period between compounds	Risk of overlapping receptor stimulation, amplified nausea, and difficulty attributing side effects to the right compound
Panicking during the washout hunger	Appetite returning is normal and temporary. Extreme restriction during washout leads to binging and unnecessary stress
Comparing week 2 of reta to month 6 of tirz	Give retatrutide 6-8 weeks before evaluating. You didn't judge tirzepatide based on week 2 either
Not tracking the transition	Without data, you can't tell your provider (or yourself) what's working. Log every dose, weight, and side effect
Increasing reta dose too fast	Rushing to 8mg+ causes the worst side effects. The 2mg to 4mg to 6mg ramp builds tolerance to the glucagon receptor gradually

Dose Conversion: There Isn't One

There is no direct dose conversion between tirzepatide and retatrutide. They have different receptor profiles, different potencies, and different pharmacokinetics. A person on 15mg tirzepatide does not "need" 12mg retatrutide.

The correct approach is always: start at 2mg retatrutide, titrate based on your individual response.

Some rough context for expectations:

4mg retatrutide typically provides similar appetite suppression to 7.5-10mg tirzepatide
8mg retatrutide typically exceeds what 15mg tirzepatide delivered, plus the added metabolic effect
12mg retatrutide is beyond anything tirzepatide can achieve at any dose

But these are generalizations. Your response will be individual. Track and adjust.

Tracking Your Transition

Track your tirz-to-reta switch — every dose, weight change, and side effect in one timeline

Smart reminders so you never miss a dose
Progress tracking with photos and weight
Medication level curves for every compound

Regimen peptide and GLP-1 tracker app screenshot

The Regimen app is built for exactly this scenario. It tracks multiple compounds on the same timeline, so you can see:

Your last tirzepatide dose and the washout period
Your first retatrutide dose and titration progress
Weight trend across the entire transition
Side effects mapped to specific dose tiers
Blood level modeling for both compounds (see when tirz levels drop and reta levels build)

This data is invaluable for your provider visits. Instead of "I think the switch is going well," you can show actual trends.

What We See in Regimen Data

Among Regimen users tracking GLP-1 compounds, retatrutide is among the most commonly tracked alongside tirzepatide — particularly in users who are also tracking peptides or testosterone. Users tracking GLP-1s and testosterone simultaneously number in the hundreds on the platform, reflecting how common combined hormonal and metabolic protocols have become.

Switching from Tirzepatide to Retatrutide

Many people transitioning between GLP-1 medications ask the same questions. Here's what the data and current protocols suggest.

How long should I wait between stopping tirzepatide and starting retatrutide?

Most users wait 1 to 2 weeks (one full tirzepatide dosing cycle) after their last dose before starting retatrutide. Tirzepatide has a half-life of approximately 5 days, so 7 to 10 days post-final-dose puts you at about 1.5 to 2 half-lives, which is generally considered sufficient overlap clearance. Longer washouts (3 to 4 weeks) reduce the chance of stacked side effects but extend the period without active medication.

What dose of retatrutide should I start with after tirzepatide?

Standard practice is to start at retatrutide 2mg weekly regardless of your tirzepatide dose. Retatrutide is a triple agonist (GLP-1, GIP, glucagon) and the glucagon component is novel, so even users at high tirzepatide doses (15mg) should not skip the retatrutide titration ladder. Typical schedule: 2mg, 4mg, 8mg, 12mg, increasing every 4 weeks if tolerated.

Can I take tirzepatide and retatrutide in the same week?

No. They're both GLP-1 agonists with overlapping mechanisms. Stacking them risks compounded GI side effects (nausea, vomiting, dehydration) and offers no proven additional weight loss benefit. Do a clean washout between compounds.

Why switch from tirzepatide to retatrutide?

The most common reasons: tirzepatide plateau (weight loss has stalled despite dose increases), dose ceiling reached (15mg is the max), or research interest in retatrutide's reported greater weight loss in phase 3 trials (about 24% vs tirzepatide's about 22.5%). Retatrutide also includes glucagon receptor agonism which may help users who plateau due to metabolic adaptation.

Frequently Asked Questions

How long after stopping tirzepatide should I start retatrutide?

One week. Both compounds have ~5-6 day half-lives, so a 7-day washout lets tirzepatide substantially clear your system before retatrutide goes in. The pause gives you a clean baseline and prevents overlapping GI side effects in week 1 of reta. Some providers skip it and start the very next week. If you do, expect a stronger nausea hit on your first reta dose because residual tirz is still active.

Will I gain weight during the washout week?

Probably 1-2 lbs, and it's not real fat. As tirzepatide clears, appetite returns, food intake creeps up, and water retention increases. The scale ticks up but body composition has barely moved. It reverses quickly once retatrutide kicks in around week 3-4. Eat at maintenance with a protein focus during the washout; aggressive restriction here just sets up a binge.

How soon will I know if retatrutide is working better than tirzepatide?

Give it 6-8 weeks, not 2. The first 2-3 weeks at 2mg are a tolerance-building phase, not a therapeutic dose. Most people don't feel the full effect until 4mg around weeks 6-7. Judging reta by week 2 is like judging tirzepatide by its first injection. Weight loss that exceeds your tirz rate usually becomes obvious between weeks 8 and 12.

Can I go back to tirzepatide if retatrutide doesn't work for me?

Yes. People do switch back, usually because reta side effects were too aggressive or because of cost and access issues. The same washout protocol applies in reverse: last reta dose, 1 week off, then restart tirzepatide at a moderate dose rather than your previous max. Your previous tirzepatide tolerance is largely preserved, and some people actually find their tirz response improves after the break.

Is it dangerous to switch between GLP-1 compounds?

Not if you do the washout. The risk of overlapping both compounds is amplified nausea and GI distress, not a medical emergency. The bigger risk is jumping straight to a high reta dose: the glucagon receptor needs its own adaptation regardless of how much GLP-1/GIP tolerance you built on tirz. Work with a provider, washout properly, and start at 2mg.

Should I switch if I'm still losing weight on tirzepatide, just slowly?

No, not yet. Slow progress on tirzepatide is not the same as a plateau. If you're still trending down, you haven't exhausted the compound. A 'slow' 0.5 lb/week is 26 lbs/year, which is significant. Switch when progress has genuinely stalled for 4+ weeks at your maximum tolerated dose, not because reta sounds shinier on a forum.

My provider doesn't know about retatrutide. What should I do?

Bring the Phase 3 trial data. Retatrutide has a published Phase 2 dose-escalation study in the New England Journal of Medicine and ongoing Phase 3 trials. Share the ClinicalTrials.gov listing and the NEJM Phase 2 paper. Most providers are open to monitoring a switch if you arrive with documentation rather than 'I read about it online.' If they still won't engage, look for a clinician experienced with peptide therapy or a metabolic health telehealth clinic.

How to Switch from Tirzepatide to Retatrutide: Protocol and Timeline